Raising $4M Series A
HourGlass has developed an transoral procedure to help morbidly obese patients lose weight. While surgeries like gastric bypass are effective and represent >$1B in sales annually, <2% of eligible patients elect treatment. HourGlass’ patented device replicates the anatomic results of proven surgeries but with an incision-free procedure performed outside expensive operating rooms in half the time. The result is a simpler, safer, and incision-free procedure for <$10k.